Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07185425 · ClinicalTrials.gov registry record · NA

Impact of the NeuroCuple Device on Pain Management After Cesarean Delivery

A NA study of Pain and Pregnancy, sponsored by Inova Health Care Services.

Recruiting
Registry status
NA
Development phase
180
Enrollment target
1
Study location

NCT07185425 is a NA study of Pain and Pregnancy that is actively recruiting participants, run by Inova Health Care Services. The registered enrollment target is 180 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (41% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07185425, a NA study of Pain and Pregnancy, is actively recruiting participants, sponsored by Inova Health Care Services.

RECRUITING
Registry status
NA
Development phase
180 participants
Enrollment target
1
Study location

Study Summary

This will be a single-center, sham-controlled, 3 arms, randomized (1:1:1) prospective study in females undergoing cesarean delivery to investigate the impact of NeuroCuple™ non-pharmacological analgesic device for management of postoperative pain. The investigators hypothesize that women treated with the Neurocuple device will experience less pain and consequently require less opioid pain medication after cesarean delivery compared to women who receive standard post-surgical medication.

Interventions

  • DEVICE Sham
  • DEVICE NeuroCuple

Study Locations (1)

Virginia

  • Inova Fairfax Medical Campus - Falls Church

Trial Details

FieldValue
Enrollment Target 180 participants
Start Date 2025-10-13
Est. Completion 2027-09
Phase NA

Sponsor

Inova Health Care Services

75 total trials

What the Registry Record Tells You About NCT07185425

The ClinicalTrials.gov registry entry for NCT07185425 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (41% lower). The listed sponsor is Inova Health Care Services, which has 75 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Sham is the first listed.

NCT07185425 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT07185425 about?

NCT07185425 is a clinical study titled "Impact of the NeuroCuple Device on Pain Management After Cesarean Delivery". This will be a single-center, sham-controlled, 3 arms, randomized (1:1:1) prospective study in females undergoing cesarean delivery to investigate the impact of NeuroCuple™ non-pharmacological analgesic device for management of postoperative pain. The investigators hypothesize that women treated wit...

What is the current status of trial NCT07185425?

This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2025-10-13. Estimated completion is 2027-09.

What conditions does trial NCT07185425 study?

This clinical trial studies the following conditions: Pain, Pregnancy, Analgesia.

What interventions are being tested in trial NCT07185425?

The interventions under investigation include: Sham (DEVICE), NeuroCuple (DEVICE).

Who is sponsoring clinical trial NCT07185425?

This trial is sponsored by Inova Health Care Services, which has 75 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07185425 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.